Relevance of ctdnajam-20261010-protocol-ccga1-validation-cso-accuracy to "Which measured methylation workflow detects tumour-derived plasma DNA and, where separately supported, identifies tissue of origin?"
- Use case
- Select a plasma ctDNA methylation detection workflow
- Assessed by
- CCGA substudy 1 validation set: cancer signal origin accuracy among jointly detected cancers
- Relevance
- Proxy evidence
- Endpoint
- Cancer signal origin accuracy among 127 validation cancers detected by all three representative classifiers, for whole-genome methylation, copy-number and white-blood-cell-corrected variant origin classifiers
A methylation-only tissue-of-origin result on patient plasma, compared with two non-methylation classifiers on the same cancers. Proxy evidence: scored only on cancers already detected by all three classifiers, with a lenient 'other' label, and developed after unblinding.
3 reviewed evaluations
- SCNA on CCGA substudy 1 validation set: cancer signal origin accuracy among jointly detected cancers
- SNV-WBC on CCGA substudy 1 validation set: cancer signal origin accuracy among jointly detected cancers
- WG methylation on CCGA substudy 1 validation set: cancer signal origin accuracy among jointly detected cancers
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
20 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Comparison group jamshidi2022-ccga1-cso Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Comparison title CCGA substudy 1: cancer signal origin accuracy Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
Constraints3 values
| Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Endpoint Cancer signal origin accuracy among 127 validation cancers detected by all three representative classifiers, for whole-genome methylation, copy-number and white-blood-cell-corrected variant origin classifiers Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Claimed field links:assessed_by:ctdnajam-20261010-protocol-ccga1-validation-cso-accuracy Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Headline metric accuracy Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
Limitations5 values
| Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
Pinned records9 values
| Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
| Rationale A methylation-only tissue-of-origin result on patient plasma, compared with two non-methylation classifiers on the same cancers. Proxy evidence: scored only on cancers already detected by all three classifiers, with a lenient 'other' label, and developed after unblinding. The CCGA samples are not public and none of the cohorts behind this use case's existing judgements comes from CCGA, so the samples do not overlap. Context-only references | Evaluation of cell-free DNA approaches for multi-cancer early detection ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction Version: Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: pdftotext -layout text layer, parsed by extract/extract_ctdna_jamshidi.py |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Evaluation of cell-free DNA approaches for multi-cancer early detection · Original source · Cancer Cell 40(12):1537-1549.e12, published 2022-12-12; publisher PDF (1-s2.0-S153561082200513X-main.pdf) as deposited by the Francis Crick Institute on figshare, 10.25418/crick.21731870.v1
Technical metadata and extraction receipts
Stable ID: use-case-mapping-ctdna-jamshidi-20261010-meth-cso
- field
- links:assessed_by:ctdnajam-20261010-protocol-ccga1-validation-cso-accuracy
- value
- ctdnajam-20261010-protocol-ccga1-validation-cso-accuracy
- relevance
- proxy
- endpoint
- Cancer signal origin accuracy among 127 validation cancers detected by all three representative classifiers, for whole-genome methylation, copy-number and white-blood-cell-corrected variant origin classifiers
- rationale
- A methylation-only tissue-of-origin result on patient plasma, compared with two non-methylation classifiers on the same cancers. Proxy evidence: scored only on cancers already detected by all three classifiers, with a lenient 'other' label, and developed after unblinding. The CCGA samples are not public and none of the cohorts behind this use case's existing judgements comes from CCGA, so the samples do not overlap.
- constraints
- Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Do not combine this mapping's evaluations with any other protocol's results; cohorts, assays and thresholds differ.; The 98% specificity threshold was set post hoc within each set and is not a locked screening threshold.
- limitations
- Scored only on 127 cancers detected by all three classifiers; no non-cancer participants.; The label 'other' covers six cancer types and counts as correct for them.; The Results and Methods name different classifier triples for the jointly detected set.; Developer study; origin classifiers developed after validation blinding was lifted; no confidence intervals printed.; The jointly detected set includes plasma cell neoplasms and leukaemias, which detection excluded; origin classifiers were rerun with them.
- citation locators
- source id: ctdnajam-20261010-source-jamshidi2022; locator: Results, cancer signal origin prediction; STAR Methods, CSO prediction
- source locator
- ctdnajam-20261010-source-jamshidi2022: Results, cancer signal origin prediction; STAR Methods, CSO prediction
- revision
- 1
- reason
- Add the CCGA substudy 1 same-sample comparison of cfDNA classifiers (Jamshidi et al. 2022), retrieved 2026-10-10.
- comparison group
- jamshidi2022-ccga1-cso
- comparison title
- CCGA substudy 1: cancer signal origin accuracy
- headline metric
- accuracy
- stratum label
- Jointly detected validation cancers
- stratum order
- 1
- reviewed evaluations
- ctdnajam-20261010-eval-cso-scna; ctdnajam-20261010-eval-cso-snv-wbc; ctdnajam-20261010-eval-cso-wg-methylation
- review
- method: automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the extractor; no human review claimed; reviewed at: 2026-10-10T09:00:00Z; note: Independent review of endpoint fit, relevance grade, limitations, exclusions and grouping against the use case and the article; every value of the listed evaluations was checked against Table 3 or the Results text, with percentages and Clopper-Pearson intervals recomputed. Developer study; no execution, reproduction, human scientific review or clinical validation.
- pins
- record id: ctdnajam-20261010-eval-cso-scna; fields: status; links; attributes.origin; attributes.comparison; sha256: fc28aaef3576b4f36f93bd6652145664ec0e6ab6c22df4453ec7b27f9f1ae4ca; record id: ctdnajam-20261010-eval-cso-snv-wbc; fields: status; links; attributes.origin; attributes.comparison; sha256: c2c98d0f5719c5effc58156aa827c738900780aade1402b5b8edc9fdbf918188; record id: ctdnajam-20261010-eval-cso-wg-methylation; fields: status; links; attributes.origin; attributes.comparison; sha256: a31bb37eea7b7a3c4d8c51a99d7a1eb3080262323028378573ae6dc928b15d99; record id: ctdnajam-20261010-protocol-ccga1-validation-cso-accuracy; fields: status; name; description; facets; source_ids; links; attributes; sha256: 1711a8afb7204176b8e663dcd23834591880f60aa05b7933bbfe2ebdc0bb5223; record id: ctdnajam-20261010-result-cso-scna-accuracy; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 98822ac7310847803b04483be6f5c8ca9a027fcf2ed5c0da9662787ee14ef8c1; record id: ctdnajam-20261010-result-cso-snv-wbc-accuracy; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 5b015790182c7139122faf8d44c4963c5dd5405fdde5b82f542aa71ed5092bbd; record id: ctdnajam-20261010-result-cso-wg-methylation-accuracy; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 6524913e0b0198f3216a1de88026bf55bc4cc48778b3b97e6d38ac6ec3ce280f; record id: ctdnajam-20261010-source-jamshidi2022; fields: status; attributes.artifact_sha256; sha256: 49c49ed0c10c6121644dee3068618d9f5a06bbc63f5979bc8417acd9c1c0e56e; record id: use-case-plasma-ctdna-methylation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429